- Abstract:
-
BACKGROUND: Leukocyte depletion at the time of transplantation with alemtuzumab (Campath-1H) has been demonstrated to be a potential strategy for reducing long-term exposure to immunosuppressive drugs. Although the impact of alemtuzumab treatment on the immune system has been explored, the effects of long-term immunosuppressive therapy in alemtuzumab-treated patients still need to be elucidated. METHODS: T-regulatory cells and Th1/Th17 responses were assessed by flow cytometry and real-time p...
Expand abstract - Publication status:
- Published
- Journal:
- Transplantation
- Volume:
- 91
- Issue:
- 7
- Pages:
- 744-750
- Publication date:
- 2011-04-05
- DOI:
- EISSN:
-
1534-6080
- ISSN:
-
0041-1337
- URN:
-
uuid:5806c8ae-8a6e-4e4b-b12b-d1237f6102e9
- Source identifiers:
-
136004
- Local pid:
- pubs:136004
- Copyright date:
- 2011
Journal article
Th17 cells in alemtuzumab-treated patients: the effect of long-term maintenance immunosuppressive therapy.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record